The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone

Immunopharmacology and Immunotoxicology

Volumn 30, Issue 2, 2008, Pages 347-364

  Kim, Hae Kyung ^a   Woo, Eun Rhan ^b   Lee, Hae Won ^a   Park, Hyung Rae ^e   Kim, Hyun Nam ^c   Jung, Yeon Kwan ^c   Choi, Je Yong ^c   Chae, Soo Wan ^a,d   Kim, Hyung Ryong ^e   Chae, Han Jung ^a,d  

^a Jeonbuk National University Medical School and Hospital   (South Korea)

^b Chosun University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Chonbuk National University   (South Korea)

^e Wonkwang University   (South Korea)

Author keywords

Cryptotanshinone; Dihydrotanshinone; LC MS MS; Osteoclastogenesis; Osteoporosis; Salvia miltiorrhiza; Tanshinone I; Tanshinone IIA

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE; CRYPTOTANSHINONE; DIHYDROTANSHINONE; METHANOL; SALVIA MILTIORRHIZA EXTRACT; TANSHINONE I; TANSHINONE IIA;

ANIMAL CELL; ANTIOSTEOCLAST ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTIOXIDANTS; BONE DENSITY CONSERVATION AGENTS; CELL DIFFERENTIATION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED ICR; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; PHENANTHRENES; PLANT EXTRACTS; RATS;

RATTUS; SALVIA MILTIORRHIZA;

EID: 45849143699     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970801949133     Document Type: Article

References (20)

1. Yokozawa, T.; Chung, H.Y.; Dong, D.; Oura, H. Confirmation that magnesium lithospermate B has a hydroxyl radical-scavenging action. Exp. Toxicol. Pathol. 1995, 47, 341-344.
2. Wu, T.W.; Zeng, L.H.; Fung, K.P.; Wu, J.; Pang, H.; Grey, A.A.; Weisel, R.D.; Wang, J.Y. Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. Biochem. Pharmacol. 1993, 46, 2327-2332.
3. Kasimu, R.; Tanaka, K.; Tezuka, Y.; Gong, Z.N.; Li, J.X.; Basnet, B.; Namba,T.; Kadota, S. Comparative study of seventeen Salvia plants: Aldose reductase inhibitory activity of water and MeOH extracts and liquid chromatography-mass spectrometry (LC-MS) analysis of water extracts. Chem. Pharm. Bull. 1998, 46, 500-504.
4. Lin, H.C.; Chang, W.L. Diterpenoids from Salvia miltiorrhiza. Phytochemistry 2000, 53, 951-953.
5. H.B. Li, F.J. Chen. Preparative isolation and purification of six diterpenoids from the Chinese medicinal plant Salvia miltiorrhiza by high-speed counter-current chromatography. J. Chromatogr. A. 2001, 925, 109-114.
6. Sieveking, D.P.; Woo, K.S.; Fung, K.P.; Lundman, O.; Nakhla, S.; Celermajor, D.S. Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. Int. J. Cardiol. 2005, 105, 40-45.
7. Yuan, S.L.; Wang, X.J.; Wei, Y.Q. Anticancer effect of tanshinone and its mechanisms. Ai Zheng 2003, 22, 1363- 1366.
8. Gao, Y.G.; Song, Y.M.; Yang, Y.Y.; Liu, W.F.; Tang, J.X. Pharmacology of tanshinone. Yao Xue Xue Bao 1979, 14, 75-82.
9. Xiao, Y.; Qing, W.X.; Lan, M.S.; Ying, C.B. Sodium trnshinone IIA sulfonate derived from Salvia miltiorrhiza Bunge up-regulate the expression of prolactin releasing peptide in the medulla oblongata in ovariectomized rats. Biochem. Pharmacol. 2006, 72, 582-587.
10. Chae, H.J.; Chae, S.W.; Yun, D.H.; Keum, K.S.; Yoo, S.K.; Kim. H.R. Prevention of bone loss in ovariectomized rats: The effect of Salvia miltiorrhiza extracts. Immunopharmacol. Immunotoxicol. 2004, 25, 135-144.
11. Kim, H.H.; Kim, J.H.; Kwak, H.B.; Huang, H.; Han, S.H.; Ha, H.; Lee, S.W.; Woo, E.R.; Lee. Z.H. Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. Biochem. Pharmacol. 2004, 67, 1647-1656.
12. Zhang, H.; Yu, C.; Jia, J.Y.; Leung, S.W.; Siow, Y.L.; Man, R.Y.; Zhu, D.Y. Contents of four active components in different commercial crude drugs and preparations of danshen (Salvia miltiorrhiza). Acta Pharmacol. Sin. 2002, 23, 1163-1168.
13. Zhang, H.; Akao, T.; Nakamura, N.; Duan, C.L.; Hattori, M.; Yang, X.W.; Liu, J.X. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat. Planta Med. 2004, 70, 138-142.
14. Park, H.; Jung, Y.K.; Park, O.J.; Lee, Y.J.; Choi, J.Y.; Choi, Y. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J. Immunol. 2005, 175, 7193- 7201.
15. Choi, J.Y.; Lee, B.H.; Song, K.B.; Park, R.W.; Kim, I.S.; Sohn, K.Y.; Jo, J.S.; Ryoo, H.M. Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells. J. Cell. Biochem. 1996, 61, 609-618.
16. Lee, S.Y.; Choi, D.Y.; Woo, E.R. Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza bunge. Arch. Pharm. Res. 2005, 28, 909-913.
17. Putnam, S.E.; Scutt, A.M.; Bicknell, K.; Priestly, C.M., Williamson, EM. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother. Res. 2007, 21, 99-112.
18. Granholm, S.; Lundberg, P.; Lerner, U.H. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-kappa B and c-Fms. J. Endocrinol. 2007, 195, 415-427.
19. Miamoto, T.; Arai, F.; Ohneda, O.; Takagi, K.; Anderson, D.M.; Suda, T. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood 2000, 96, 4335-4343.
20. Kwak, H.B.; Yang, D.; Ha, H.; Lee, J.H.; Kim, H.N.; Woo, E.R.; Lee, S.; Kim, H.H.; Lee, Z.H. Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Exp. Mol. Med. 2006, 38, 256-264.